13.01.2025 15:34:50
|
CareDx Expects Q4 30% Increase In Q4 Preliminary Revenue, Shares Up In Premarket
(RTTNews) - CareDx, Inc. (CDNA), Monday reported preliminary loss for the fourth quarter and a 30 percent increase preliminary revenues.
For the quarter, the company projects loss to be approximately $32 to $34 million and adjusted EBITDA to be between $8 and $9 million.
Quarterly preliminary revenue is expected to increase to a range of $85 to $86 million.
Meanwhile, for the full year 2024, loss is estimated to be between $58 million and $60 million and revenue is expected to be between $332 million to $333 million.
Looking forward to the fiscal year 2025, CareDx sees revenue of $370 million.
In the pre-market hours, CareDx's stock is trading at $25.08, up 6.14 percent on the Nasdaq.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu CareDx Incmehr Nachrichten
03.11.24 |
Ausblick: CareDx stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) | |
20.10.24 |
Erste Schätzungen: CareDx gewährt Anlegern Blick in die Bücher (finanzen.net) |
Analysen zu CareDx Incmehr Analysen
Aktien in diesem Artikel
CareDx Inc | 21,54 | -0,05% |
|